Therapeutic Inertia in 19 Percent With T2DM, HbA1c ≥8 Percent
HbA1c values of 8.0 to 9.9, >10 percent, diabetes duration ≥20 years linked to tx intensification
June 2017 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for June 2017. This roundup includes the latest...
Clindamycin, TMP-SMX Linked to Better Outcomes for Abscesses
Clindamycin or trimethoprim-sulfamethoxazole ups short-term outcomes vs incision, drainage alone
In HIV, Greater BMD Decline for Immediate Versus Delayed ART
After one year, change in bone mineral density was similar in the immediate and deferred groups
EPO Doping Has Little Effect on Real-World Cycling Performance
Appears to improve high-intensity performance, not endurance or road race performance
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
Many Women Have Questions, Concerns About Tamoxifen
Study shows that normal symptoms of menopause are often attributed to tamoxifen
Psychological Risks Higher in Atopic Dermatitis Patients
However, this does not translate into increased use of health care services, suicide
Nivolumab Rx Beyond Progression Beneficial in Melanoma
28 percent of patients treated beyond progression had lesion reduction >30 percent
T1DM Patients With Active β-Cell Function Differ Immunologically
Findings for patients with remaining endogenous β-cell function after 10 or more years of T1DM
